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Conclusion: The differences between the intra-fraction 
patient displacements observed through CTV overlapping 
using CBCTs and through the surface markers registration 
seem to be clinically acceptable for the PTV considered. The 
relatively greater spread using markers is probably due to the 
larger portion of patient’s surface covered by the OTS 
compared to the CTV region. Considering the adopted PTV 
margin, the non-invasive OTS could be therefore used to 
monitor the intra-fraction movements as alternative to a post 
treatment CBCT, possibly using markers positioned in a 
restricted area around the target. 
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Purpose or Objective: SBRT is now an accepted treatment 
for inoperable pts with stage I lung cancer and 
oligometastatic disease.Particularly for SBRT, tumor motion 
must be taken into consideration due to high dose per 
fraction. It is unclear which system provides the best 
accuracy for target localization.The aim of this study is to 
evaluate the role of lung optimization treatment(LOT) 
simulation for the best tumor tracking using Cyberknife SBRT. 
 
Material and Methods: From September 2014 to July 2015 we 
evaluated 143 consecutive pts referred to our department for 
tracking modality.For everyone a CT scan was performed in 
expiratory and inspiratory phase.During the simulation the 
position and setup were the same as those during the 
treatment. The real-time images were compared to the DRRs 
where the target was evidenced.Cyberknife includes a small 
6 MV LINAC mounted on a robotic arm,two diagnostic X-ray 
sources (installed in the ceiling of the treatment room) 
attached to digital image collectors, placed orthogonally to 
the patient to provide real-time treatment guidance, and a 
table remotely controlled that can move around different 
axes and adjust the patient position. 
 
Results: According to the accuracy of the LOT system in 
target identification we observed these solutions:we treated 
102 pts (71%) with Xsight lung technique, 80 pts in 2-view 
modality in which the target was recognized and tracked 
from both X-Ray cameras and 22 pts in 1-view modality,in 
which only one camera was used. XSight lung along with 
Synchrony Respiratory Tracking can automatically track and 
adjust the beam to tumor motion, using the lesion as a 
fiducial.The GTVs were expanded by 3 mm in all directions to 
create the CTVs .We used different margins for PTVs. In the 
2-view modality the CTV on expiratory CT was expanded by 
2mm in all directions,while for 1 view modality two different 
CTVs were generated on both CT scan to include the entire 
inhale-to-exhale tumor motion, and added together to create 
an ITV expanded by 2 mm in the direction followed by the X-
Ray camera and 3mm in the other direction.For the other 40 
lesions (29%),when the tumor cannot be clearly identified by 
either of the two cameras,fiducials have been necessary. 
 
Conclusion: LOT simulation system is a very effective, useful 
and non-invasive technique. Dramatically reducing PTV 
margins and consequently the risk of potential toxicities 
related to the high doses, LOT simulation system and Xsight 
lung are considered the best choice in the management of 
lung lesions in our clinical practice. 
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Purpose or Objective: We report the preliminary clinical 
results organ motion mitigation strategies in the treatment of 
moving target with active scanned carbon ion beams. 
 
Material and Methods: Since September 2014 26 patients 
with tumors located in the upper abdomen and chest were 
treated with active scanned carbon ion beams. Patients were 
affected by pancreatic adenocarcinoma, HCC, biliary tract 
cancers and sarcoma of the spine retroperitoneum and heart. 
Tight thermoplastic mask was selected as the optimal 
abdominal compression device. 4D CT scan with retrospective 
reconstruction, with phase signal obtained with Anzai system 
(Anzai Medical CO., LTD), was employed for planning. 
Automatic assignment of raw data to respiratory phases was 
checked and, if necessary, modified by the medical physicist. 
Planning was performed using end expiration phase. Planning 
CT scans were visually checked for motion artifacts. 
Contouring was performed on end expiration phase and on 
the adjacent 30% expiration and 30% inspiration phases. 
Beam entrance was selected in order to avoid the bowel in 
the entrance channel. The lung diaphragm interface was 
contoured in the different respiratory phases and beam 
angles were chosen to avoid passing tangential to the lung 
diaphragm ITV. IMPT was used for plan optimization. Plans 
were recalculated in adjacent phases and if DVHs were 
degraded in an unacceptable way they were modified 
iteratively. Weekly verification 4D CT scans were performed 
and, if needed, a new plan was re-optimized adaptively. Set 
up was verified with gated orthogonal X rays and non-gated 
cone beam CT in treatment room. Threshold for gate-on 
signal was initially set at 10% pressure signal dynamic and 
qualitatively adjusted in an asymmetric way according to 
results of plan recalculation in 30% expiration and inspiration. 
Gating signal was fed to the accelerator to enable beam 
delivery. Each slice was re-scanned 5 times to smear out 
possible interplay effects. Acute and early toxicity was 
scored according to CTCAE 4.0 scale. 
 
Results: GTV and diaphragm excursion between end 
expiration and adjacent 30% phases was reduced to less than 
5 mm. GTV (D95%) and critical OARs (D1%) DVH in 30% 
inspiration and expiration phases showed on average minimal 
(less than 1%) differences as compared to planning end 
expiration plan. Toxicity was minimal with no G3 event. G2 
toxicity was observed in 15% of the patient during treatment 
and in 10% of the patients at 3 months. Median follow up was 
rather short (3 months) nevertheless in 23 patients the dose 
limiting OAR was either stomach or small bowel or esophagus 
, therefore early toxicity data are informative. 
 
Conclusion: Active scanning with carbon ion beams for the 
treatment of moving target using abdominal compression, 4D 
simulation, robust planning, gating and rescanning is feasible 
and safe . Longer follow up is needed to evaluate oncological 
outcome. 
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Purpose or Objective: Application of principal component 
analysis (PCA) to fiducial marker coordinate during 
respiratory cycle provides new axes including the first 
principal component (1st PC), which presents maximal 
motion direction. The purpose of this study is to investigate 
correlation of respiratory motion between the markers 
implanted in the lung and interfractional variation in 
directionality of the 1st PC. 
 
Material and Methods: Marker motion data in consecutive 9 
patients who had 4 or 5 gold fiducials implanted in the lung 
and received tumor-tracking stereotactic body radiotherapy 
in 4 fractions were analyzed. Superior–Inferior (SI)/ Left–
Right (LR)/ Anterior–Posterior (AP) positional data were 
acquired using a pair of orthogonal fluoroscopy in every 
fraction with the frame rate of 6.25 or 12.5 per second. 
Fifty-five datasets were eligible. The acquired SI/LR/AP 
coordinates were processed by PCA for each marker in all 
patients to calculate cumulative contribution ratio, principal 
component scores from 1st to 3rd PC and eigenvector of the 
1st PC. Motion amplitude was defined as the 95th percentile 
of 1st PC scores. We evaluated (1) contribution ratio (CR) of 
the 1st PC, (2) correlation of the 1st PC scores between 
different markers in each fraction and (3) angles formed by 
1st PC eigenvector of the first fraction and those of the 
others (defined as Ang1i (i=2, 3, 4)) for each marker. 
 
Results: Mean ± standard deviation (SD) of motion amplitude 
in the 1st PC direction was 20.2 ± 11 mm. Median 
contribution ratio (CR) of 1st PC was 0.933 (range: 0.721–
0.996). Median correlation coefficient of 1st PC score among 
the markers was 0.985 (range: 0.938–0. 999). For all markers, 
Ang1i varied from 1.19 to 23.3 degrees (deg) as shown in the 
Figure. Mean ± SD of Ang1i in 7 patients whose 1st PC 
directions seemed stable was 3.4 ± 1.03 deg, while 2 patients 
had larger variation (18.8 and 11.3 deg on average). The 
markers with larger interfractional variations in directionality 
had the tendency to be more affected by heartbeat or 
possess small motion amplitude with round shape orbit. 
 
 
 
Conclusion: The 1st PC of the marker coordinate during 
breathing generally provided a good explanation of its 
respiratory motion in the lung. Strong correlations in motion 
along the 1st PC direction between different markers were 
indicated. Interfractional variation in motion direction stayed 
small in most cases. 
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Purpose or Objective: The aim of this study is to evaluate 
the efficacy of motion mitigation tools in reducing 
respiration-induced target motion and to investigate the 
concordance of redundant breathing motion monitoring 
systems during gating treatments in radiotherapy with 
accelerated particles. 
 
Material and Methods: In our institution, a gating protocol 
for carbon ion therapy has been developed and since 2014 it 
is applied to lesions affected by non-negligible organ motion. 
It involves both abdominal compression (through tight 
thermoplastic body masks) and active beam rescanning. 4DCT 
is used to image anatomy variations between end-inspiration 
(EI) and end-expiration (EE) phases. Treatment is optimized 
on the EE phase and it is delivered in a gate-on window 
centered on it. Both 4DCT binning and gate-on trigger rely on 
the Anzai load cell system (Anzai Medical CO, LTD). To 
quantify the efficacy of abdominal compression, we 
evaluated the 3D GTV displacements observed between EE 
and EI phases of the planning 4DCT. A B-spline-based 
deformable registration algorithm was used to calculate the 
displacement field between EE and EI. GTV contours, as 
segmented in EE, were then propagated to the EI. In 
addition, an in-room optical tracking system (OTS) provided 
continuous breathing monitoring by localizing a set of surface 
markers. Each time the gating window was opened by the 
Anzai system, markers coordinates were stored and compared 
offline, in terms of 3D displacements, with the initial setup 
configuration. This solution allowed us to measure and 
quantify the intra-fraction concordance of surface 
surrogates.  
Data of six patients with thoracic and abdominal lesions has 
been evaluated. 
 
Results: A median (interquartile) 3D GTV displacement (EE-
EI) of 5.8 (2.0) mm, in a range of 1.4-10.9 mm, was observed. 
The maximum displacements (absolute values) were noticed 
in superior-inferior direction (range: 0.1-9.3 mm). Overall 
mean values of markers 3D displacements between setup 
conditions and data acquired during irradiation by the OTS 
were found to be lower than a millimeter (range: 0.1-0.7 
mm). We observed an intra-fractional significant difference 
among different irradiation fields, thus suggesting a small 
trend towards progressive deterioration of reproducibility 
during treatment delivery. 
 
Conclusion: Target 3D displacements, as calculated from the 
EE and EI phases, can be considered relevantly lower than 
those reported in literature for thoraco-abdominal lesions. 
These preliminary results suggest that patient’s respiratory 
pattern (and thus target trajectory) can often be reduced by 
means of appropriate immobilization/compression tools. 
During treatment delivery, sub-millimeter values of 3D 
discrepancies in surface surrogates detection demonstrate 
that the Anzai and the OTS operate consistently, therefore a 
